The impact of national centralized drug procurement policy on firm performance: Evidence from Chinese pharmaceutical firms

Authors:
  • HHHuan He
    Huan He
  • YZYuanzhu Zhan
    Yuanzhu Zhan
  • BHBaofeng Huo
    Baofeng Huo
  • YZYufeng Zhang
    Yufeng Zhang
  • XSXiaojie Shi
    Xiaojie Shi

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (72091214, 71821002)

This publication has 90 references indexed in Scilit: